US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class II · Moderate risk Terminated

PHENYLephrine HCl 1.5%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0085-2020
Class II · Moderate risk Terminated

Phenylephrine HCl 1.5%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0084-2020
Class II · Moderate risk Terminated

Nicotinamide Adenine Dinucleotide

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0079-2020
Class II · Moderate risk Terminated

NEOstigmine Methylsulfate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0078-2020
Class II · Moderate risk Terminated

NEOstigmine Methylsulfate

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0077-2020
Class II · Moderate risk Terminated

Moxifloxacin 0.1% in BSS

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0076-2020
Class II · Moderate risk Terminated

Moxifloxacin 0.1% in BSS

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0075-2020
Class II · Moderate risk Terminated

Methionine 750 mg / Inositol 1

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0072-2020
Class II · Moderate risk Terminated

LIDOcaine 2%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0071-2020
Class II · Moderate risk Terminated

LIDOcaine HCl 2%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0069-2020
Class II · Moderate risk Terminated

LIDOcaine HCl 1%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0068-2020
Class II · Moderate risk Terminated

LIDOcaine HCl 0.75%

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0067-2020
Class II · Moderate risk Terminated

Labetalol HCl 5 mg/mL 20 mg/4 mL

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0066-2020
Class II · Moderate risk Terminated

Ketamine in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility

KRS Global Biotechnology, Inc D-0065-2020